We are live on
!
Find out more
SELLAS Life Sciences
15 hedge funds and large institutions have $3.16M invested in SELLAS Life Sciences in 2018 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
4,000% more call options, than puts
Call options by funds: $164K | Put options by funds: $4K
51% more capital invested
Capital invested by funds: $2.1M → $3.16M (+$1.06M)
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
7% more funds holding
Funds holding: 14 → 15 (+1)
0.08% more ownership
Funds ownership: 0.18% → 0.26% (+0.08%)
Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
–
Closed
5
Calls
$164K
Puts
$4K
Net Calls
+$160K
Net Calls Change
-$318K
Top Buyers
| 1 |
6CM
683 Capital Management
New York
|
+$1.76M |
| 2 |
Renaissance Technologies
New York
|
+$580K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$245K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$108K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$23.5K |
Top Sellers
| 1 |
VF
Virtu Financial
New York
|
-$41K |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$34K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$2.42K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$414 |
